Back to search

University of British Columbia

Exercise influence on taxane side effects in women with breast cancer

Abstract

dc:description

Taxane-based chemotherapy is frequently administered to treat breast cancer. However, side effects of taxanes include chemotherapy-induced peripheral neuropathy (CIPN) and cardiovascular complications, which negatively impact patient quality of life and long-term health. Exercise can significantly reduce cancer treatment side effects. However, information on exercise’s influence on taxane-specific side effects is limited. The primary aim of this dissertation was to evaluate the effect of exercise on taxane side effects, including CIPN and cardiovascular outcomes, in women with breast cancer. METHODS: Women with early-stage breast cancer were randomized to thrice-weekly exercise (EX) or usual care (UC) during taxane chemotherapy (4 cycles, 2-3 weeks apart). Patient-reported CIPN symptoms and quality of life (EORTC QLQ-C30 + CIPN20 subscale), clinical CIPN tests (vibration sensation and pinprick), patient-reported pain (Brief Pain Inventory) and cardiovascular outcomes, including heart rate and blood pressure at rest, and during and after submaximal exercise testing, were evaluated at baseline (pre-taxane chemotherapy) and end of chemotherapy. CIPN symptoms and quality of life were also evaluated at 0-3 days pre-chemotherapy cycle 4. RESULTS: Twenty-four women enrolled (EX: n=11, UC: n=13). Patient-reported CIPN symptoms were significantly worse by the end of chemotherapy in both groups for sensory (p<0.01) and motor symptoms (p=0.04), with a trend towards reduced sensory symptom progression among exercisers (p=0.08). Significantly more participants in the usual care group had impaired vibration sensation at 0-3 days pre-chemotherapy cycle 4 at the left interphalangeal joint (UC: 80%, EX: 10%, p<0.01), with a similar trend for the right interphalangeal joint (UC: 60%, EX: 10% p=0.06). Resting heart rate was significantly lower by the end of chemotherapy in the exercise group (EX: 71±2, UC: 77±2 bpm, p<0.05). The exercise group also had significantly lower heart rates during submaximal exercise testing (p<0.01) and significantly faster heart rate recovery (p=0.02) by the end of chemotherapy. Lastly, a non-significant trend towards higher blood pressure during submaximal exercise testing was observed among the usual care group by the end of chemotherapy. CONCLUSION: This study provides preliminary evidence supporting the positive influence of exercise on CIPN and cardiovascular outcomes in early-stage breast cancer patients undergoing taxane chemotherapy.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Rehabilitation Sciences
Grantor dc:publisher
University of British Columbia
Year dc:date
2017

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Bland, Kelcey Ann

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/63312

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Bland, Kelcey Ann. Exercise influence on taxane side effects in women with breast cancer. master's thesis, University of British Columbia, 2017. http://hdl.handle.net/2429/63312